023910.KQ
Price:
$25900
Market Cap:
$152.29B
Operating from South Korea, Daihan Pharmaceutical Co.,Ltd. focuses on the development, manufacturing, and distribution of therapeutic medications. The company's diverse product portfolio features physician-prescribed drugs, over-the-counter (OTC) remedies, quasi-pharmaceuticals, and a variety of intravenous infusion solutions. Established in 1945, the firm's corporate headquarters are situated in Seoul, South Korea.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2000-10-19
Stock Exchange
KOE
Ticker
023910.KQ
According to Daihan Pharmaceutical Co.,Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 92.74B. This represents a change of -21.57% compared to the average of 118.24B of the last 4 quarters.
The mean historical Enterprise Value of Daihan Pharmaceutical Co.,Ltd. over the last ten years is 148.81B. The current 92.74B Enterprise Value has changed 6.13% with respect to the historical average. Over the past ten years (40 quarters), 023910.KQ's Enterprise Value was at its highest in in the June 2018 quarter at 285.66B. The Enterprise Value was at its lowest in in the September 2023 quarter at 62.95B.
Average
148.81B
Median
146.55B
Minimum
63.14B
Maximum
251.61B
Discovering the peaks and valleys of Daihan Pharmaceutical Co.,Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 46.95%
Maximum Annual Enterprise Value = 251.61B
Minimum Annual Increase = -36.06%
Minimum Annual Enterprise Value = 63.14B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 128.03B | 37.99% |
| 2024 | 92.78B | 46.95% |
| 2023 | 63.14B | -36.06% |
| 2022 | 98.75B | -11.81% |
| 2021 | 111.98B | -32.16% |
| 2020 | 165.06B | -6.70% |
| 2019 | 176.91B | -22.10% |
| 2018 | 227.09B | -9.74% |
| 2017 | 251.61B | 45.63% |
| 2016 | 172.78B | 22.72% |
The current Enterprise Value of Daihan Pharmaceutical Co.,Ltd. (023910.KQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
94.65B
5-year avg
98.94B
10-year avg
148.81B
Daihan Pharmaceutical Co.,Ltd.’s Enterprise Value is
| Company | Enterprise Value | Market cap |
|---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Daihan Pharmaceutical Co.,Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Daihan Pharmaceutical Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Daihan Pharmaceutical Co.,Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Daihan Pharmaceutical Co.,Ltd. (023910.KQ)?
What is the 3-year average Enterprise Value for Daihan Pharmaceutical Co.,Ltd. (023910.KQ)?
What is the 5-year average Enterprise Value for Daihan Pharmaceutical Co.,Ltd. (023910.KQ)?
How does the current Enterprise Value for Daihan Pharmaceutical Co.,Ltd. (023910.KQ) compare to its historical average?